Preclinical and Clinical Due Diligence

Aepodia provides Clinical Due Diligence (from preclinical pharmacology data up to Phase 2 clinical data) to evaluate:

  • The pertinence of available preclinical and clinical data.
  • The interpretation of available compound information.
  • The level of quality and regulatory compliance.
  • The robustness of the IP.

This evaluation is summarized in a technical report and a SWOT analysis.

Our network of consultants and experts in various areas (toxicology, pre-clinical drug metabolism, chemistry, GLP and GMP) ensure complete and efficient due diligence execution.